在早期乳腺癌中对新辅助疗法的病理完整反应后的预后:基于人口的研究
Caroline Boman1,2, Christian Tranchell2, Xingrong Liu1
1Oncology/Pathology Department, Karolinska Institutet, Stockholm, Sweden.
Journal of the National Comprehensive Cancer Network : JNCCN
|March 12, 2025
概括
乳腺癌新辅助化疗 (NACT) 后实现病理完整反应 (pCR) 的患者的长期结果有所不同. 基线瘤特征影响预后,表明需要个性化NACT后策略.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 乳腺癌治疗方法 乳腺癌治疗方法
背景情况:
- 新辅助化疗 (NACT) 后的病理完整反应 (pCR) 是早期乳腺癌的关键预后因素.
- 然而,即使在实现pCR后,也存在剩余复发风险,因此需要对长期结果进行进一步调查.
- 这项研究探讨了在实现pCR的患者中结果的异质性.
研究的目的:
- 确定影响非转移性乳腺癌在NACT后获得PCR的患者长期结果的因素.
- 了解这个患者子组的基线瘤特征的预后影响.
主要方法:
- 一项基于人口的队列研究,涉及2007年至2020年期间在斯德哥尔摩-戈特兰地区接受NACT治疗的患者.
- 主要终点:远程无复发生存率 (DRFS),定义为从手术到远程复发或死亡的时间.
- 分析包括年龄,瘤阶段,HER2和激素受体状态等因素.
主要成果:
- 在2487名患者中,26.6%的人实现了pCR.
- 在pCR组中,与改善的DRFS相关的因素包括年龄较小,较低的T阶段和HER2阳性.
- 节点阳性预测了早期的远程复发,而雌激素受体阳性预测了晚期复发 (5-10年).
结论:
- 在NACT后实现PCR的患者代表了一个异质的群体,具有不同的长期预后.
- 基线瘤特征对于分层风险和指导后新辅助疗法决策至关重要.
- 考虑初始瘤生物学的个性化治疗策略对于优化乳腺癌患者实现pCR的结果至关重要.
相关概念视频
01:21Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K